• 1
    Gabay C., Lamacchia, C. and Palmer, G., IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 2010. 6: 232241.
  • 2
    Evans, R. J., Bray, J., Childs, J. D., Vigers, G. P., Brandhuber, B. J., Skalicky, J. J., Thompson, R. C. et al., Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta. J. Biol. Chem. 1995. 270: 1147711483.
  • 3
    Dinarello, C. A., Biologic basis for interleukin-1 in disease. Blood 1996. 87: 20952147.
  • 4
    Hirsch, E., Irikura, V. M., Paul, S. M. and Hirsh, D., Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA 1996. 93: 1100811013.
  • 5
    Ma, Y., Thornton, S., Boivin, G. P., Hirsh, D., Hirsch, R. and Hirsch, E., Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist. Arthritis Rheum. 1998. 41: 17981805.
  • 6
    Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R. et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 2009. 360: 24262437.
  • 7
    Reddy, S., Jia, S., Geoffrey, R., Lorier, R., Suchi, M., Broeckel, U., Hessner, M. J. et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N. Engl. J. Med. 2009. 360: 24382444.
  • 8
    Nicklin, M. J., Hughes, D. E., Barton, J. L., Ure, J. M. and Duff, G. W., Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 2000. 191: 303312.
  • 9
    Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T. et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 2000. 191: 313320.
  • 10
    Tilg, H., Vogel, W., Wiedermann, C. J., Shapiro, L., Herold, M., Judmaier, G. and Dinarello, C. A., Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology 1993. 18: 11321138.
  • 11
    Muto, Y., Nouri-Aria, K. T., Meager, A., Alexander, G. J., Eddleston, A. L. and Williams, R., Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988. 2: 7274.
  • 12
    Sekiyama, K. D., Yoshiba, M. and Thomson, A. W., Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin. Exp. Immunol. 1994. 98: 7177.
  • 13
    Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nolchen, B., Judmaier, G. and Huber, C., Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992. 103: 264274.
  • 14
    Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S. et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 1994. 179: 15291537.
  • 15
    Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., 3rd, Tannahill, C. L., Solorzano, C. C., Norman, J. et al. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J. Immunol. 1998. 160: 40824089.
  • 16
    Gramantieri, L., Casali, A., Trere, D., Gaiani, S., Piscaglia, F., Chieco, P., Cola, B. et al. Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. Clin. Exp. Immunol. 1999. 115: 515520.
  • 17
    Fujioka, N., Mukaida, N., Harada, A., Akiyama, M., Kasahara, T., Kuno, K., Ooi, A. et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J. Leukoc. Biol. 1995. 58: 9098.
  • 18
    Arend, W. P., Malyak, M., Guthridge, C. J. and Gabay, C., Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 1998. 16: 2755.
  • 19
    Haskill, S., Martin, G., Van Le, L., Morris, J., Peace, A., Bigler, C. F., Jaffe, G. J. et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 1991. 88: 36813685.
  • 20
    Bigler, C. F., Norris, D. A., Weston, W. L.and Arend, W. P., Interleukin-1 receptor antagonist production by human keratinocytes. J. Invest. Dermatol. 1992. 98: 3844.
  • 21
    Muzio, M., Polentarutti, N., Facchetti, F., Peri, G., Doni, A., Sironi, M., Transidico, P. et al. Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra. Eur. J. Immunol. 1999. 29: 781788.
  • 22
    Gabay, C., Smith, M. F., Eidlen, D. and Arend, W. P., Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J. Clin. Invest. 1997. 99: 29302940.
  • 23
    Malyak, M., Smith, M. F., Jr., Abel, A. A., Hance, K. R. and Arend, W. P., The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. J. Immunol. 1998. 161: 20042010.
  • 24
    Lamacchia, C., Palmer, G., Bischoff, L., Rodriguez, E., Talabot-Ayer, D. and Gabay, C., Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice. J. Immunol. 2010. 185: 25162524.
  • 25
    Tiegs, G., Hentschel, J. and Wendel, A., A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992. 90: 196203.
  • 26
    Leist, M. and Wendel, A., A novel mechanism of murine hepatocyte death inducible by concanavalin A. J. Hepatol. 1996. 25: 948959.
  • 27
    Tagawa, Y., Sekikawa, K. and Iwakura, Y., Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 1997. 159: 14181428.
  • 28
    Tagawa, Y., Kakuta, S. and Iwakura, Y., Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur. J. Immunol. 1998. 28: 41054113.
  • 29
    McMillan, P. N., Ferayorni, L. S., Gerhardt, C. O. and Jauregui, H. O., Light and electron microscope analysis of lectin binding to adult rat liver in situ. Lab. Invest. 1984. 50: 408420.
  • 30
    Malyak, M., Guthridge, J. M., Hance, K. R., Dower, S. K., Freed, J. H. and Arend, W. P., Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J. Immunol. 1998. 161: 19972003.
  • 31
    Gabay, C., Gigley, J., Sipe, J., Arend, W. P. and Fantuzzi, G., Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur. J. Immunol. 2001. 31: 490499.
  • 32
    Lee, R. T., Briggs, W. H., Cheng, G. C., Rossiter, H. B., Libby, P. andKupper, T., Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. J. Immunol. 1997. 159: 50845088.
  • 33
    Wilson, H. L., Francis, S. E., Dower, S. K. and Crossman, D. C., Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2×7 receptor activation. J. Immunol. 2004. 173: 12021208.
  • 34
    Watson, J. M., Lofquist, A. K., Rinehart, C. A., Olsen, J. C., Makarov, S. S., Kaufman, D. G. and Haskill, J. S., The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta. J. Immunol. 1995. 155: 44674475.
  • 35
    Garat, C. and Arend, W. P., Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. Cytokine 2003. 23: 3140.
  • 36
    Merhi-Soussi, F., Berti, M., Wehrle-Haller, B. and Gabay, C., Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility. Cytokine 2005. 32: 163170.
  • 37
    Palmer, G., Trolliet, S., Talabot-Ayer, D., Mezin, F., Magne, D. and Gabay, C., Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1). Cytokine 2005. 31: 153160.
  • 38
    Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 1999. 274: 305315.
  • 39
    Lamacchia, C., Palmer, G., Seemayer, C. A., Talabot-Ayer, D. and Gabay, C., Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis. Rheum. 2010. 62: 452462.